All Stories

  1. Focusing the Controversies in Budd-Chiari Syndrome Management
  2. Portal Hypertension
  3. Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?
  4. Left Ventricular Diastolic Dysfunction in β-Thalassemia Major with Heart Failure
  5. Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis
  6. Timing of transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: An Italian hepatologist’s perspective
  7. Management of hepatocellular carcinoma in thalassemia and importance of the human factor
  8. Prognostic Assessment and Management of Liver Cirrhosis
  9. Time to resize the role of liver transplant for Budd-Chiari syndrome
  10. Letter: management of portal vein thromboses in cirrhosis
  11. Letter: why treatments of hepatitis C virus are less effective in cirrhosis
  12. Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant
  13. Letter: hepatocellular carcinoma in thalassaemia - emerging issues and challenges for liver transplant
  14. Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?
  15. Letter: target of TIPSS for Budd-Chiari syndrome should be avoiding liver transplant
  16. Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation
  17. TIPS for Budd–Chiari syndrome: time to anticipate treatment
  18. Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue
  19. Cirrhosis development probably arises from chronic micro-vascular ischemia
  20. Budd-chiari syndrome management: Timing of treatment is an open issue
  21. Diarrhea as sole presentation of Good's syndrome mimicking Crohn's disease
  22. Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation
  23. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction
  24. Management of portopulmonary hypertension: New perspectives
  25. Malignancy and Radiation-Induced Cardiotoxicity
  26. Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation
  27. Budd-Chiari syndrome management: Lights and shadows
  28. Music for colonoscopy: A single-blind randomized controlled trial
  29. Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure
  30. Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long‐term follow up
  31. A Prospective Study of Hepatocellular Carcinoma Incidence in Thalassemia
  32. Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic
  33. TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience
  34. Assessment of blood coagulation in severe liver disease using thromboelastography
  35. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
  36. The incidence of esophageal varices in cirrhosis
  37. Prognostic indicators in cirrhosis: The role of child classification. Overview of 56 published studies and validation in a prospective cohort of patients